Elvira Bisbe

Dr. Elvira Bisbe

Department of Anesthesiology, University Hospital Mar-Esperanza, 08003 Barcelona, Spain
orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in British Journal of Anaesthesia
Verified
Journal Article
Open access
LGL.T. Goodnough
L.T. Goodnough
AMA Maniatis
A Maniatis
PEP Earnshaw
P Earnshaw
GBG Benoni
G Benoni
PBP Beris
P Beris
MSM Szpalski
M Szpalski
Previously undiagnosed anaemia is common in elective orthopaedic surgical patients and is associated with increased likelihood of blood transfusion and increased perioperative morbidity and mortality. A standardized approach for the detection, evaluation, and management of anaemia in this setting has been identified as an unmet medical need. A multidisciplinary panel of physicians was convened by the Network for Advancement of Transfusion Alternatives (NATA) with the aim of developing practice guidelines for the detection, evaluation, and management of preoperative anaemia in elective orthopaedic surgery. A systematic literature review and critical evaluation of the evidence was performed, and recommendations were formulated according to the method proposed by the Grades of Recommendation Assessment, Development and Evaluation (GRADE) Working Group. We recommend that elective orthopaedic surgical patients have a haemoglobin (Hb) level determination 28 days before the scheduled surgical procedure if possible (Grade 1C). We suggest that the patient's target Hb before elective surgery be within the normal range, according to the World Health Organization criteria (Grade 2C). We recommend further laboratory testing to evaluate anaemia for nutritional deficiencies, chronic renal insufficiency, and/or chronic inflammatory disease (Grade 1C). We recommend that nutritional deficiencies be treated (Grade 1C). We suggest that erythropoiesis-stimulating agents be used for anaemic patients in whom nutritional deficiencies have been ruled out, corrected, or both (Grade 2A). Anaemia should be viewed as a serious and treatable medical condition, rather than simply an abnormal laboratory value. Implementation of anaemia management in the elective orthopaedic surgery setting will improve patient outcomes.

31 July 2018 in Anaesthesia
Verified
Journal Article
Open access
PDF file
MMManuel Muñoz
Manuel Muñoz
AAA. G. Acheson
A. G. Acheson
Elvira BisbeElvira Bisbe
Elvira Bisbe
ABA. Butcher
A. Butcher
SGS. Gómez‐Ramírez
S. Gómez‐Ramírez
AKA. A. Klein
A. A. Klein
Summary: Despite numerous guidelines on the management of anaemia in surgical patients, there is no pragmatic guidance for the diagnosis and management of anaemia and iron deficiency in the postoperative period. A number of experienced researchers and clinicians took part in a two‐day expert workshop and developed the following consensus statement. After presentation of our own research data and local policies and procedures, appropriate relevant literature was reviewed and discussed. We developed a series of best‐practice and evidence‐based statements to advise on patient care with respect to anaemia and iron deficiency in the postoperative period. These statements include: a diagnostic approach to iron deficiency and anaemia in surgical patients; identification of patients appropriate for treatment; and advice on practical management and follow‐up that is easy to implement. Available data allow the fulfilment of the requirements of Pillar 1 of Patient Blood Management. We urge national and international research funding bodies to take note of these recommendations, particularly in terms of funding large‐scale prospective, randomised clinical trials that can most effectively address the important clinical questions and this clearly unmet medical need.

1 April 2020 in JAMA Surgery
Verified
Journal Article
Open access
PDF file
JRJavier Ripollés-Melchor
Javier Ripollés-Melchor
AAAne Abad-Motos
Ane Abad-Motos
YDYolanda Díez-Remesal
Yolanda Díez-Remesal
MAMarta Aseguinolaza-Pagola
Marta Aseguinolaza-Pagola
LPLidia Padin-Barreiro
Lidia Padin-Barreiro
R(Research Network (REDGERM)
Research Network (REDGERM)
An estimated 310 million patients undergo surgery worldwide each year.1 In the United States, 1 million total hip arthroplasty (THA) and total knee arthroplasty (TKA) procedures are performed annually, with an expectation of growth in the coming years.2 The International Surgical Outcomes Study3 showed that 16.5% of patients who underwent orthopedic surgery experienced complications. The incidence of complications in THA and TKA was 3.2% to 8.0%,4 with an important variability between centers.4,5 Postoperative complications after THA and TKA have been shown to increase hospital length of stay (LOS).6 Kehlet7 described the concept of the multimodal approach to recovery in 1997. The Enhanced Recovery After Surgery (ERAS) program that entails an evidenced-based protocol based on a wide literature search was initiated by Ljungqvist et al8 in the ERAS study group, which later developed into the ERAS Society. The ERAS protocol includes a variable number of multidisciplinary perioperative measures whose initial goal is to improve recovery and reduce morbidity, which will result in secondary benefits, including reductions in LOS, convalescence, and costs.9 Observational studies10 and randomized clinical trials11 have shown that ERAS was associated with improved outcomes in patients undergoing THA and TKA, mainly a decrease in LOS.12,13

10 April 2019 in Acta Haematologica
Verified
Journal Article
Closed access
PDF file
SGSusana Gómez-Ramírez
Susana Gómez-Ramírez
Elvira BisbeElvira Bisbe
Elvira Bisbe
ASAryeh Shander
Aryeh Shander
DSDonat R. Spahn
Donat R. Spahn
MMManuel Muñoz
Manuel Muñoz
Preoperative anemia affects 30–40% of patients undergoing major surgery and is an independent risk factor for perioperative blood transfusion, morbidity, and mortality. Absolute or functional iron deficiency is its leading cause. Nonanemic hematinic deficiencies are also prevalent and may hamper preoperative hemoglobin optimization and/or recovery from postoperative anemia. As modifiable risk factors, anemia and hematinic deficiencies should be detected and corrected prior to major surgical procedures. Postoperative anemia is even more common (up to 80–90%) due to surgery-associated blood loss, inflammation-induced blunted erythropoiesis, and/or preexisting anemia. Preoperative oral iron may have a role in mild-to-moderate anemia, provided there is sufficient time (6–8 weeks) and adequate tolerance of oral preparations. Postoperative oral iron is of little value and rife with gastrointestinal adverse events. Intravenous iron should preferentially be used in cases of moderate-to-severe iron deficiency anemia, concomitant use of erythropoiesis-stimulating agents, short time to surgery or nonelective procedures, and for postoperative anemia management. Minor infusion reactions to intravenous iron are rare, the incidence of severe anaphylactic reactions is extremely low, and there is no increase in infections with intravenous iron. Currently available intravenous iron formulations allowing administration of large single doses are preferred.

1 September 2011 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
Elvira BisbeElvira Bisbe
Elvira Bisbe
JGJosé Antonio García-Erce
José Antonio García-Erce
ADA.I. Díez-Lobo
A.I. Díez-Lobo
MMM. Muñoz
M. Muñoz

11 December 2007 in Vox Sanguinis
Verified
Journal Article
Open access
PDF file
MMManuel Muñoz
Manuel Muñoz
CBC. Breymann
C. Breymann
JGJosé Antonio García-Erce
José Antonio García-Erce
SGS. Gómez‐Ramírez
S. Gómez‐Ramírez
JCJ. Comin
J. Comin
Elvira BisbeElvira Bisbe
Elvira Bisbe
Anaemia is a common condition among patients admitted to hospital medicosurgical departments, as well as in critically ill patients. Anaemia is more frequently due to absolute iron deficiency (e.g. chronic blood loss) or functional iron deficiency (e.g. chronic inflammatory states), with other causes being less frequent. In addition, preoperative anaemia is one of the major predictive factors for perioperative blood transfusion. In surgical patients, postoperative anaemia is mainly caused by perioperative blood loss, and it might be aggravated by inflammation‐induced inhibition of erythropoietin and functional iron deficiency (a condition that cannot be corrected by the administration of oral iron). All these mechanisms may be involved in the anaemia of the critically ill. Intravenous iron administration seems to be safe, as very few severe side‐effects were observed, and may result in hastened recovery from anaemia and lower transfusion requirements. However, it is noteworthy that many of the recommendations given for intravenous iron treatment are not supported by a high level of evidence and this must be borne in mind when making decisions regarding its application to a particular patient. Nonetheless, this also indicates the need for further large, randomized controlled trials on the safety and efficacy of intravenous iron for the treatment of anaemia in different clinical settings.